Lakewood Asset Management’s AbbVie ABBV Stock Holding History

Lakewood Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$236K	Buy	1,086 +3	+0.3%	+$665	0.15%	97
2025 Q4	$247K	Buy	1,083 +3	+0.3%	+$683	0.15%	91
2025 Q3	$250K	Buy	+1,080	New	+$220K	0.15%	87
2025 Q2	–	Sell	-1,177	Closed	-$247K	–	102
2025 Q1	$247K	Sell	1,177 -407	-26%	-$79.1K	0.17%	87
2024 Q4	$281K	Buy	1,584 +9	+0.6%	+$1.66K	0.19%	93
2024 Q3	$311K	Buy	1,575 +7	+0.4%	+$1.31K	0.21%	89
2024 Q2	$269K	Buy	1,568 +9	+0.6%	+$1.49K	0.19%	97
2024 Q1	$284K	Buy	1,559 +4	+0.3%	+$689	0.19%	91
2023 Q4	$241K	Sell	1,555 -418	-21%	-$60.9K	0.19%	96
2023 Q3	$294K	Buy	1,973 +5	+0.3%	+$734	0.24%	88
2023 Q2	$265K	Buy	1,968 +5	+0.3%	+$733	0.21%	93
2023 Q1	$313K	Buy	1,963 +4	+0.2%	+$612	0.26%	82
2022 Q4	$317K	Buy	+1,959	New	+$300K	0.26%	76

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Lakewood Asset Management's ABBV Position: Q1 2026 in Review

Lakewood Asset Management increased its AbbVie (ABBV) stake by 0.28% in Q1 2026, buying an estimated $665 and bringing the position to 1,086 shares worth $236K. The position accounts for 0.15% of the portfolio, ranked #97.

Lakewood Asset Management first reported a position in ABBV in Q4 2022 and has held it in 13 quarters since. The position peaked at $317K in Q4 2022. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Lakewood Asset Management held 1,086 shares of AbbVie worth $236K as of Q1 2026.
Lakewood Asset Management bought 3 AbbVie shares in Q1 2026, an estimated $665.
AbbVie made up 0.15% of Lakewood Asset Management's portfolio in Q1 2026, its #97 holding.
Lakewood Asset Management first reported a position in AbbVie in Q4 2022 and has held it in 13 quarters since.
Lakewood Asset Management's AbbVie position peaked at $317K in Q4 2022.
4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Lakewood Asset Management's 13F filing for Q1 2026, filed 23 Apr 2026.